BIO2017 recap, FDA approves Roche’s rapid-acting Rituxan, but rejects Pfizer’s Epogen biosimilar, and more - scroll down for the latest news
click here for the latest message board posts
click here for the latest on pharma/biotech social media
click here for the latest on device social media
For banking news and anonymous forums, be sure to check out cafebanking.com
